CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 4 Shares withheld for taxes SR. VP, GENERAL COUNSEL & SEC. gave up 2,071 shares (to pay taxes)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $64.88 ($25,952)
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $61.37 ($24,548)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Results of operations · Regulation FD disclosure
Page 9 of 90 · 1,784 filings